Who Exports Ceftazidime from India — 228 Suppliers Behind a $10.7M Market
India's ceftazidime export market is supplied by 228 active exporters who collectively shipped $10.7M across 920 shipments. ZEISS PHARMACEUTICALS PRIVATE LIMITED leads with a 19.5% market share, followed by ANANTA MEDICARE LIMITED and VENUS REMEDIES LIMITED. The top 5 suppliers together control 46.4% of total export value, reflecting a moderately competitive market structure.
Top Ceftazidime Exporters from India — Ranked by Export Value
ZEISS PHARMACEUTICALS PRIVATE LIMITED is the leading ceftazidime exporter from India, holding a 19.5% share of the $10.7M market across 920 shipments from 228 exporters. The top 5 suppliers — ZEISS PHARMACEUTICALS PRIVATE LIMITED, ANANTA MEDICARE LIMITED, VENUS REMEDIES LIMITED, THEON PHARMACEUTICALS LIMITED, SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI — collectively control 46.4% of total export value, indicating a competitive market. Individual shares are: ZEISS PHARMACEUTICALS PRIVATE LIMITED (19.5%), ANANTA MEDICARE LIMITED (14.9%), VENUS REMEDIES LIMITED (6.8%), THEON PHARMACEUTICALS LIMITED (3.2%), SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI (2.1%).
Top Ceftazidime Exporters from India
Ranked by export value · 228 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ZEISS PHARMACEUTICALS PRIVATE LIMITED INNO-ZIDIME 1.0GM CEFTAZIDIME FOR INJECT | $2.1M | 1 | 19.5% |
| 2 | ANANTA MEDICARE LIMITED FLORAZIDE POWDER FOR SOLUTION FOR 1G INVIAL NO.1DENIZID, POWDER FOR SOLUTION FOR 1G IN VIAL NO.1FLORAZIDE, POWDER FOR SOLUTION, 1G IN VIAL NO.1 | $1.6M | 3 | 14.9% |
| 3 | VENUS REMEDIES LIMITED INJECTION AMIZIDIME 1G CEFTAZIDIME FOR INJECTION USP 1GCEFTAZIDIME VIAL 1000 MG/20 ML #1 BATCHCEFTAZIDIME FOR INJECTION 1000MG BATCH N | $722.5K | 15 | 6.8% |
| 4 | THEON PHARMACEUTICALS LIMITED ZAVITAPHARMCEUTICAL PRODUCTS- CEFTAZISAPHNOVAZIDIME | $338.3K | 4 | 3.2% |
| 5 | SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI INJECTION AMIZIDIME 1G CEFTAZIDIME FOR INJECTION USP 1GCEFTAZIDIME VIAL 1000 MG/20 ML #1 BATCHPHARMCEUTICAL PRODUCTS- CEFTAZISAPH | $225.7K | 3 | 2.1% |
| 6 | BIOCOLL PHARMACEUTICALS PRIVATE LIMITED TAZIDIME 1000MGTIZIME 1G POWDER FOR INJECTION -PHARMA:TIZIME INJECTION 1GM (CEFTAZIDIME | $201.3K | 2 | 1.9% |
| 7 | KILITCH DRUGS INDIA LIMITED INJECTION AMIZIDIME 1G CEFTAZIDIME FOR INJECTION USP 1GPHARMCEUTICAL PRODUCTS- CEFTAZISAPHNOVAZIDIME | $193.0K | 2 | 1.8% |
| 8 | STRIDES PHARMA SCIENCE LIMITED BETAZIDIM FOI USP 1G-MEX-CEFTAZIDIME INJCEFTAZIDIME SP 1000 (CEFTAZIDIME FOR INJKEFTAZ 1 GM INJECTION CEFTAZIDIME FOR IN | $186.5K | 1 | 1.7% |
| 9 | JPC GLOBAL | $186.2K | 1 | 1.7% |
| 10 | INJECT CARE PARENTERALS PRIVATE LIMITED INJECTION AMIZIDIME 1G CEFTAZIDIME FOR INJECTION USP 1GZAVITASYNER-ZED 1 G CEFTAZIDIME FOR INJECTION | $172.9K | 2 | 1.6% |
| 11 | EVOLET HEALTHCARE PRIVATE LIMITED CEFTAZIDIME VIAL 1000 MG/20 ML #1 BATCHCEFTAZIDIME FOR INJECTION 1000MG BATCH N | $168.5K | 1 | 1.6% |
| 12 | SANCE LABORATORIES PRIVATE LIMITED FLORAZIDE POWDER FOR SOLUTION FOR 1G INVIAL NO.1DENIZID, POWDER FOR SOLUTION FOR 1G IN VIAL NO.1FLORAZIDE, POWDER FOR SOLUTION, 1G IN VIAL NO.1 | $159.5K | 5 | 1.5% |
| 13 | BHARAT PARENTERALS LIMITED PREXIDIM, N-1 (CEFTAZIDIME 1000MG FOR INCEFTAZIDIME FOR INJECTION USP 1GM. BIOFO | $154.2K | 1 | 1.4% |
| 14 | GOD GIFT LABORATORY PRIVATE LIMITED | $152.5K | 1 | 1.4% |
| 15 | IND SWIFT LIMITED PREXIDIM, N-1 (CEFTAZIDIME 1000MG FOR ININJECTION AMIZIDIME 1G CEFTAZIDIME FOR INJECTION USP 1GCEFTAZIDIME VIAL 1000 MG/20 ML #1 BATCH | $149.4K | 3 | 1.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Ceftazidime exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| STRIDES PHARMA SCIENCE LIMITED | Warning Letter, January 2 | Yes, as of 2019 | Yes | Not specified | Received FDA warning letter in January 2019; holds WHO-GMP and EU GMP certificat |
| IND SWIFT LIMITED | Warning Letter, 2011 | Yes, as of 2011 | Yes | Not specified | Received FDA warning letter in 2011; holds WHO-GMP and EU GMP certifications. |
TransData Nexus reviewed the regulatory standing of 2 leading Ceftazidime exporters from India. 0 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 2 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Ceftazidime sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of active pharmaceutical ingredients (APIs). The city's pharmaceutical sector is characterized by a robust infrastructure and a skilled workforce, making it a pivotal hub for API manufacturing. While specific data on Ceftazidime production in Hyderabad is not readily available, the city's capacity for large-scale API synthesis suggests a significant role in its production.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a prominent center for pharmaceutical formulations. This region hosts numerous manufacturing units specializing in the production of finished dosage forms. Companies such as SiNi Pharma, based in Ahmedabad, are involved in the manufacturing and export of Ceftazidime injections, indicating the region's active participation in the formulation and distribution of this antibiotic.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for Indian pharmaceuticals. Mumbai, being a major port city, facilitates the international distribution of pharmaceutical products. Cipla Limited, headquartered in Mumbai, is a notable player in the pharmaceutical industry, contributing to the export of various drugs. While specific figures for Ceftazidime exports from this region are not specified, the presence of such companies underscores the area's significance in global pharmaceutical trade.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is recognized as Asia's largest pharmaceutical hub, housing over 3,100 factories. The region's appeal is enhanced by favorable tax incentives, attracting numerous pharmaceutical companies. While specific data on Ceftazidime production in Baddi-Nalagarh is not detailed, the region's extensive manufacturing capabilities suggest a potential role in its production and distribution.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and compliance standards of potential suppliers to ensure consistent product quality.
- Monitor Export Trends: Stay informed about export data and market demands to align sourcing strategies with current trends.
- Leverage Regional Strengths: Utilize the specific strengths of each pharmaceutical cluster to optimize the supply chain for Ceftazidime.
By strategically sourcing from India's diverse pharmaceutical clusters, companies can enhance the resilience and efficiency of their Ceftazidime supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Ceftazidime exporters from India
Venus Remedies Limited — Venus Remedies secures first generic Ceftazidime + Avibactam approval in Indonesia
Venus Remedies received marketing authorization from Indonesian regulators for its antibiotic combination, Ceftazidime + Avibactam, marking its first anti-infective approval in Indonesia. - IMPACT: This approval is expected to enhance Venus Remedies' export capabilities for Ceftazidime-based products in Southeast Asia.
Impact: This approval is expected to enhance Venus Remedies' export capabilities for Ceftazidime-based products in Southeast Asia.
Scott-Edil Advance Research Laboratories & Education Limited — Scott-Edil obtains approval for Ceftriaxone in Mozambique
Scott-Edil Advance Research Laboratories & Education Limited received authorization for its Ceftriaxone 1g product in Mozambique, expanding its market presence in Africa. (anarme.gov.mz) - IMPACT: This approval may lead to increased exports of Ceftazidime and related antibiotics to African markets.
Impact: This approval may lead to increased exports of Ceftazidime and related antibiotics to African markets.
Theon Pharmaceuticals Limited — Theon Pharmaceuticals secures approval for Ceftriaxone in Mozambique
Theon Pharmaceuticals Limited obtained authorization for its Ceftriaxone 1g product in Mozambique, enhancing its footprint in the African pharmaceutical market. (anarme.gov.mz) - IMPACT: This development is likely to boost Theon's exports of Ceftazidime and similar antibiotics to African nations.
Impact: This development is likely to boost Theon's exports of Ceftazidime and similar antibiotics to African nations.
Common Questions — Ceftazidime Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which ceftazidime supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ZEISS PHARMACEUTICALS PRIVATE LIMITED leads with 8 recorded shipments worth $2.1M. ANANTA MEDICARE LIMITED (21 shipments) and VENUS REMEDIES LIMITED (73 shipments) are also established high-volume exporters.
Q How many ceftazidime manufacturers are there in India?
India has 228 active ceftazidime exporters with a combined export market of $10.7M across 920 shipments to 99 countries. The top 5 suppliers hold 46.4% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for ceftazidime from India?
Average FOB unit price: $17.38 per unit, ranging from $0.00 to $510.00. Average shipment value: $11.6K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 228 verified Indian exporters of Ceftazidime ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 920 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 99 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
920 Verified Shipments
228 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists